Purdue Pharma (PDP) Receives $5.5 Billion Sentence for Opioid Misconduct

Purdue Pharma has been sentenced to $5.5 billion in fines and penalties following its guilty plea in 2020 for fraudulently marketing OxyContin. This resolution allows the company to file for bankruptcy and allocate funds to a $7.4 billion settlement for victims of the opioid crisis. U.S. District Judge Madeline Cox Arleo noted that accountability has been limited since the Department of Justice did not charge individual executives, leaving most of the fines unpaid as Purdue directs assets toward repaying creditors. The developments are significant as they may influence future corporate accountability in similar cases.